Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xphyto Therapeutics Corp (XPHY.CN)

Xphyto Therapeutics Corp (XPHY.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xphyto Therapeutics Corp 1820 Fir Street Suite 270 Vancouver BC V6J 3B1 CAN

P: 780-818-6422

Description:

XPhyto Therapeutics Corp is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.

Key Statistics

Overview:

Market Capitalization, $K 46,517
Shares Outstanding, K 91,210
Annual Sales, $ 286 K
Annual Net Income, $ -20,637 K
Last Quarter Sales, $ 98 K
Last Quarter Net Income, $ -1,353 K
60-Month Beta 0.10
% of Institutional Shareholders 0.06%

Growth:

1-Year Return -60.77%
3-Year Return -49.00%
5-Year Return 0.00%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.19
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -36.67%
Dividend Payout Ratio 0.00%

XPHY.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -546.00%
Return-on-Assets % -175.72%
Profit Margin % -7,203.23%
Debt/Equity 1.39
Price/Sales 78.80
Price/Book 30.69
Book Value/Share 0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar